Ming-Qiang Zheng

According to our database1, Ming-Qiang Zheng authored at least 9 papers between 2010 and 2022.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

On csauthors.net:

Bibliography

2022
Age, gender and body-mass-index relationships with <i>in vivo</i> CB<sub>1</sub> receptor availability in healthy humans measured with [<sup>11</sup>C]OMAR PET.
NeuroImage, 2022

2020
Separating dopamine D<sub>2</sub> and D<sub>3</sub> receptor sources of [<sup>11</sup>C]-(+)-PHNO binding potential: Independent component analysis of competitive binding.
NeuroImage, 2020

2016
Imaging of cerebral α<sub>4</sub>β<sub>2</sub>* nicotinic acetylcholine receptors with (-)-[<sup>18</sup>F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
NeuroImage, 2016

2014
Evaluation of the agonist PET radioligand [<sup>11</sup>C]GR103545 to image kappa opioid receptor in humans: Kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
NeuroImage, 2014

2010
Synthesis and evaluation of [C-11]LY2795050, an antagonist PET imaging tracer for the kappa opioid receptors.
NeuroImage, 2010

Kinetic analysis of the kappa agonist tracer [11C]GR103545 in healthy controls.
NeuroImage, 2010

Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: Test-retest reproducibility and gender differences.
NeuroImage, 2010

Imaging the kappa opioid receptor in humans with [11C]LY2795050: Tracer evaluation and test-retest reproducibility study.
NeuroImage, 2010

Imaging drug-induced dopamine release in rhesus monkeys with [<sup>11</sup>C]PHNO versus [<sup>11</sup>C]raclopride PET.
NeuroImage, 2010


  Loading...